The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial
Authors:
- Elizabeth A MilesEMElizabeth A Miles
- Edwin G.A AirdEAEdwin G.A Aird
- Peter J HoskinPHPeter J Hoskin
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 71 (3) , 303-310
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Three-dimensional dose distribution of tangential breast irradiation: results of a multicentre phantom dosimetry studyRadiotherapy and Oncology, 2000
- A comparative description of three multipurpose phantoms (MPP) for external audits of photon beams in radiotherapy: the water MPP, the Umeå MPP and the EC MPP.Radiotherapy and Oncology, 2000
- Tangential breast irradiation: a multi-centric intercomparison of dose using a mailed phantom and thermoluminescent dosimetry.Radiotherapy and Oncology, 1999
- Thermoluminescence dosimetry applied to in vivo dose measurements for total body irradiation techniquesRadiotherapy and Oncology, 1998
- A comparison of the effectiveness of thermoluminescent crystals LiF:Mg,Ti, and LiF:Mg,Cu,P for clinical dosimetryMedical Physics, 1997
- An audit of radiotherapy patient doses measured with in vivo semiconductor detectors.British Journal of Radiology, 1997
- Quality control of radiotherapy centres in Europe: beam calibrationRadiotherapy and Oncology, 1994
- Preliminary results of a quality assurance network for radiotherapy centres in EuropeRadiotherapy and Oncology, 1993
- Entrance and exit TL-dosimetry in the conservative treatment of breast cancer: a pilot study for the EORTC-radiotherapy cooperative groupRadiotherapy and Oncology, 1991
- In vivo dosimetry during tangential breast treatmentRadiotherapy and Oncology, 1991